Madrigal Pharmaceuticals <MDGL.O>: Barclays cuts target price to $962 from $964
MDGL•Related News
BCB Bancorp posts Q2 net loss on higher credit costs
BCBP•
Opus Genetics completes enrollment in Phase 3 trial of OPGx-LCA5 gene therapy for LCA5 retinal disease
IRD•
Glaukos publishes investor presentation highlighting interventional glaucoma, keratoconus pipeline programs
GKOS•
Marriott falls on Q3 profit forecast below estimates
MAR•
Douglas Dynamics Q2 sales rise 10% on strong pre-season orders at unit
PLOW•